title: [Preservation of the bladder in transitional cell tumors infiltrating the lamina propria].
abstract: Thirty-two patients with transitional cell cancer of the bladder infiltrating the lamina propria were treated with intravesical BCG. Seventy-five percent of these patients could keep their bladder at the cost of regular BCG treatment and strict endoscopic monitoring. A better evaluation of prognostic criteria, including malignancy grade, total amount of vesical muscle removed during the initial resection and investigation for lymphatic system emboli, should help in a better selection of patients, separating those who might have recurrent infiltrative tumours from those who would benefit from a conservative treatment and offering the former a more aggressive therapy.
authors.affiliation: Service d'Urologie, Hôpital de Bicêtre, Université Paris-Sud.
authors.forename: G
authors.initials: G
authors.lastname: Benoît
authors.forename: L
authors.initials: L
authors.lastname: Alexandre
authors.forename: H
authors.initials: H
authors.lastname: Bensadoun
authors.forename: A
authors.initials: A
authors.lastname: Vieillefond
authors.forename: P R
authors.initials: PR
authors.lastname: Martin
authors.forename: A
authors.initials: A
authors.lastname: Martin
authors.forename: A
authors.initials: A
authors.lastname: Jardin
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000628:therapy*
chemical_list: D001500:BCG Vaccine
vernacular_title: Préservation de la vessie dans les tumeurs paramalpighiennes infiltrant le chorion.